Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,089 | -4,456 | -20,880 | -12,979 | -12,346 |
| Depreciation Amortization | 335 | 564 | 3,464 | 1,855 | 1,226 |
| Accounts receivable | -43 | -160 | -3,583 | -4,029 | -1,638 |
| Other Working Capital | 206 | -611 | -5,432 | -5,550 | -4,414 |
| Other Operating Activity | -510 | 191 | 12,867 | 10,454 | 9,783 |
| Operating Cash Flow | $-8,101 | $-4,472 | $-13,564 | $-10,249 | $-7,389 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -221 | -1,284 | -1,192 | -400 |
| Net Acquisitions | N/A | N/A | -1,091 | -656 | N/A |
| Purchase Of Investment | N/A | N/A | -200 | -200 | -200 |
| Purchase Sale Intangibles | N/A | -32 | -126 | -73 | -63 |
| Other Investing Activity | 963 | -32 | -126 | -73 | -63 |
| Investing Cash Flow | $959 | $-253 | $-2,701 | $-2,121 | $-663 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,137 | 8,000 | 8,000 |
| Debt Repayment | -27 | -713 | -4,897 | -4,837 | -4,768 |
| Common Stock Issued | N/A | N/A | 11,385 | 4,799 | 1,775 |
| Other Financing Activity | -832 | 0 | -287 | -287 | -287 |
| Financing Cash Flow | $-859 | $-713 | $16,338 | $7,675 | $4,720 |
| Exchange Rate Effect | 61 | -32 | 16 | N/A | N/A |
| Beginning Cash Position | 9,891 | 9,891 | 9,802 | 9,502 | 9,502 |
| End Cash Position | 1,951 | 4,421 | 9,891 | 4,807 | 6,170 |
| Net Cash Flow | $-7,940 | $-5,470 | $89 | $-4,695 | $-3,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,101 | -4,472 | -13,564 | -10,249 | -7,389 |
| Capital Expenditure | -4 | -221 | -1,284 | -1,192 | -400 |
| Free Cash Flow | -8,105 | -4,693 | -14,848 | -11,441 | -7,789 |